Vinícius Bernardo de Oliveira, João Marcos Oliveira-Silva, Giovanna De Souza Maciel, Marcos Samuel Souza Paulino, Laís Bernardo Lopes, Larissa Pereira Damasceno, Maria Eduarda do Vale Uliniki Teixeira, Angel Mauricio Castro-Gamero
{"title":"Non-clonal interphase markers of chromosomal instability in malignancy acquisition and cancer progression","authors":"Vinícius Bernardo de Oliveira, João Marcos Oliveira-Silva, Giovanna De Souza Maciel, Marcos Samuel Souza Paulino, Laís Bernardo Lopes, Larissa Pereira Damasceno, Maria Eduarda do Vale Uliniki Teixeira, Angel Mauricio Castro-Gamero","doi":"10.1016/j.mrfmmm.2026.111944","DOIUrl":null,"url":null,"abstract":"<div><div>Chromosomal instability (CIN) is a pervasive feature of cancer and a major driver of tumor heterogeneity, evolution, and therapeutic resistance. Arising predominantly from defects in chromosome segregation, DNA repair, and mitotic fidelity, CIN promotes continuous genomic diversification within tumor cell populations, enabling adaptive responses to intrinsic and extrinsic selective pressures. While clonal chromosomal alterations reflect stabilized genomic configurations selected during tumor evolution, non-clonal interphase markers of chromosomal instability represent transient, low-frequency events that capture ongoing microevolutionary dynamics and genomic plasticity. This review provides a comprehensive synthesis of current knowledge regarding both classical and non-classical markers of CIN evaluated during interphase, including micronuclei, nucleoplasmic bridges, nuclear buds, cytoplasmic chromatin, massive chromosomal segregation errors, chromosomal fragmentation, and genomic chaos-related phenomena. We discuss the cellular mechanisms underlying their formation, their contribution to structural and numerical chromosomal alterations, and their role in shaping intratumoral heterogeneity, adaptive potential, malignancy acquisition, and cancer progression. Particular emphasis is placed on the \"just-right\" dual nature of CIN, which can either drive tumor aggressiveness or precipitate mitotic catastrophe and cell death, depending on its magnitude and cellular context. By integrating cytogenetic, molecular, and evolutionary perspectives, this review highlights the relevance of these non-clonal interphase cytogenetic markers as sensitive indicators of genome instability and tumor dynamics. Understanding the interplay between clonal and non-clonal chromosomal alterations may provide valuable insights for the development of prognostic tools and therapeutic strategies aimed at exploiting the vulnerabilities of genomically unstable cancers.</div></div>","PeriodicalId":49790,"journal":{"name":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","volume":"833 ","pages":"Article 111944"},"PeriodicalIF":2.4000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1386196426000175","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chromosomal instability (CIN) is a pervasive feature of cancer and a major driver of tumor heterogeneity, evolution, and therapeutic resistance. Arising predominantly from defects in chromosome segregation, DNA repair, and mitotic fidelity, CIN promotes continuous genomic diversification within tumor cell populations, enabling adaptive responses to intrinsic and extrinsic selective pressures. While clonal chromosomal alterations reflect stabilized genomic configurations selected during tumor evolution, non-clonal interphase markers of chromosomal instability represent transient, low-frequency events that capture ongoing microevolutionary dynamics and genomic plasticity. This review provides a comprehensive synthesis of current knowledge regarding both classical and non-classical markers of CIN evaluated during interphase, including micronuclei, nucleoplasmic bridges, nuclear buds, cytoplasmic chromatin, massive chromosomal segregation errors, chromosomal fragmentation, and genomic chaos-related phenomena. We discuss the cellular mechanisms underlying their formation, their contribution to structural and numerical chromosomal alterations, and their role in shaping intratumoral heterogeneity, adaptive potential, malignancy acquisition, and cancer progression. Particular emphasis is placed on the "just-right" dual nature of CIN, which can either drive tumor aggressiveness or precipitate mitotic catastrophe and cell death, depending on its magnitude and cellular context. By integrating cytogenetic, molecular, and evolutionary perspectives, this review highlights the relevance of these non-clonal interphase cytogenetic markers as sensitive indicators of genome instability and tumor dynamics. Understanding the interplay between clonal and non-clonal chromosomal alterations may provide valuable insights for the development of prognostic tools and therapeutic strategies aimed at exploiting the vulnerabilities of genomically unstable cancers.
期刊介绍:
Mutation Research (MR) provides a platform for publishing all aspects of DNA mutations and epimutations, from basic evolutionary aspects to translational applications in genetic and epigenetic diagnostics and therapy. Mutations are defined as all possible alterations in DNA sequence and sequence organization, from point mutations to genome structural variation, chromosomal aberrations and aneuploidy. Epimutations are defined as alterations in the epigenome, i.e., changes in DNA methylation, histone modification and small regulatory RNAs.
MR publishes articles in the following areas:
Of special interest are basic mechanisms through which DNA damage and mutations impact development and differentiation, stem cell biology and cell fate in general, including various forms of cell death and cellular senescence.
The study of genome instability in human molecular epidemiology and in relation to complex phenotypes, such as human disease, is considered a growing area of importance.
Mechanisms of (epi)mutation induction, for example, during DNA repair, replication or recombination; novel methods of (epi)mutation detection, with a focus on ultra-high-throughput sequencing.
Landscape of somatic mutations and epimutations in cancer and aging.
Role of de novo mutations in human disease and aging; mutations in population genomics.
Interactions between mutations and epimutations.
The role of epimutations in chromatin structure and function.
Mitochondrial DNA mutations and their consequences in terms of human disease and aging.
Novel ways to generate mutations and epimutations in cell lines and animal models.